326
Participants
Start Date
June 14, 2019
Primary Completion Date
April 30, 2025
Study Completion Date
April 30, 2025
Oral azacitidine
Oral azacitidine (CC-486) 200 mg tablet
Matched placebo
Oral azacitidine (CC-486) matched placebo tablet
The Queen Elizabeth Hospital, Birmingham
University Hospital Bristol, Bristol
Addenbrooke's Hospital, Cambridge
University Hospital of Wales, Cardiff
Queen Elizabeth University Hospital, Glasgow
St. James's University Hospital, Leeds
Leicester Royal Infirmary, Leicester
Clatterbridge Cancer Centre, Liverpool
Hammersmith Hospital, London
King's College Hospital, London
St Bartholomew's Hospital, London
The Royal Marsden Hospital, London
University College London Hospitals, London
Manchester Royal Infirmary, Manchester
The Christie Hospital, Manchester
Freeman Hospital, Newcastle
Nottingham City Hospital, Nottingham
Churchill Hospital, Oxford
Derriford Hospital, Plymouth
Royal Hallamshire Hospital, Sheffield
University of Birmingham
OTHER